Front. Aging Neurosci., 2023 · DOI: 10.3389/fnagi.2023.1152297 · Published: May 18, 2023
Spinal cord injury (SCI) often leads to irreversible sensory and motor dysfunction, resulting in lifelong disability of patients and a heavy burden on society. Currently, there is no effective cure for SCI. Neuroinflammation plays an important role in secondary injury and studying the mechanism of neuroinflammation may provide potential therapeutic targets for treating SCI. Pyroptosis is inflammatory-related programmed cell death and the gasdermin protein family is the executioner of pyroptosis.
The identified pyroptosis-related genes and their regulatory mechanisms offer potential therapeutic targets for treating spinal cord injury by modulating neuroinflammation.
The predicted Traditional Chinese Medicine (TCM) and small drug-like molecules with NLRP3/PRGs as potential targets can be further explored for drug development.
Understanding the differential expression of pyroptosis-related genes in different SCI models can lead to personalized treatment strategies.